MX9801603A - Alteraciones geneticas relacionadas con la enfermedad de alzheimer hereditaria. - Google Patents

Alteraciones geneticas relacionadas con la enfermedad de alzheimer hereditaria.

Info

Publication number
MX9801603A
MX9801603A MX9801603A MX9801603A MX9801603A MX 9801603 A MX9801603 A MX 9801603A MX 9801603 A MX9801603 A MX 9801603A MX 9801603 A MX9801603 A MX 9801603A MX 9801603 A MX9801603 A MX 9801603A
Authority
MX
Mexico
Prior art keywords
disease
methods
genetic alterations
familial alzheimer
same
Prior art date
Application number
MX9801603A
Other languages
English (en)
Other versions
MXPA98001603A (es
Inventor
Rudolph E Tanzi
Wilma Wasco
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of MX9801603A publication Critical patent/MX9801603A/es
Publication of MXPA98001603A publication Critical patent/MXPA98001603A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711Alzheimer's disease; Amyloid plaque core protein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Se proporcionan moléculas aisladas de ácidos nucleicos que codifican productos de genes PS1 humanos. Los polipéptidos mutantes de PS1 también se proporcionan así como los vectores, células huéspedes y métodos recombinantes para producir los mismos. La invencion además se relaciona con métodos de examen para identificar agonistas y antagonistas de la actividad del polipéptido PS1 y mutantes del mismo. También se proporcionan métodos de diagnosticos para detectar la enfermedad de Alzheimer y métodos terapéuticos para el tratamiento de la misma.
MXPA/A/1998/001603A 1995-08-31 1998-02-27 Alteraciones geneticas relacionadas con la enfermedad de alzheimer hereditaria MXPA98001603A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US305495P 1995-08-31 1995-08-31
US003054 1995-08-31
US08/706,344 US6248555B1 (en) 1995-08-31 1996-08-30 Genetic alterations related to familial alzheimer's disease
US08706344 1996-08-30
PCT/US1996/014114 WO1997008319A1 (en) 1995-08-31 1996-09-03 Genetic alterations related to familial alzheimer's disease

Publications (2)

Publication Number Publication Date
MX9801603A true MX9801603A (es) 1998-08-30
MXPA98001603A MXPA98001603A (es) 1998-11-12

Family

ID=

Also Published As

Publication number Publication date
US6248555B1 (en) 2001-06-19
WO1997008319A1 (en) 1997-03-06
US20010012626A1 (en) 2001-08-09
EP0851921A1 (en) 1998-07-08
JPH11512929A (ja) 1999-11-09
CA2230654A1 (en) 1997-03-06

Similar Documents

Publication Publication Date Title
WO1998039446A3 (en) 70 human secreted proteins
WO1998039448A3 (en) 186 human secreted proteins
WO1998040483A3 (en) 28 human secreted proteins
WO1998030694A3 (en) TUMOR NECROSIS FACTOR RECEPTORS 6α AND 6$g(b)
EP1015468A4 (en) FOLLISTATIN-3
WO1998031800A3 (en) Human proteins
CY1111950T1 (el) 32 ανθρωπινες εκκρινομενες πρωτεϊνες
WO2001036432A3 (en) 18 human secreted proteins
NZ279963A (en) Human tissue inhibitor of metalloproteinase-4 (timp-4) and dna (rna) encoding polypeptide which may be derived from atcc 75946
WO1998045712A3 (en) 20 human secreted proteins
WO2001012776A3 (en) 18 human secreted proteins
WO2001034768A3 (en) 15 human secreted proteins
WO2000017222A8 (en) 31 human secreted proteins
WO2000077026A8 (en) 49 human secreted proteins
WO2000063230A3 (en) 49 human secreted proteins
WO2001012775A3 (en) 25 human secreted proteins
WO2000058339A3 (en) 50 human secreted proteins
MX9801603A (es) Alteraciones geneticas relacionadas con la enfermedad de alzheimer hereditaria.
WO2000043495A3 (en) 33 human secreted proteins
WO2000061624A8 (en) 48 human secreted proteins
ATE300554T1 (de) Bindegewebe-wachstumsfaktor 3.
WO2003052377A9 (en) 41 human secreted proteins
WO2000061596A8 (en) 50 human secreted proteins
WO2001034769A3 (en) 24 human secreted proteins
WO2001023409A8 (en) 38 human secreted proteins

Legal Events

Date Code Title Description
FA Abandonment or withdrawal